Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_NEW |
Aggregated Age/sex: 15+ Female |
2015 |
50,517 |
CARE_NEW |
Aggregated Age/sex: 15+ Male |
2015 |
30,671 |
CARE_NEW |
Sum of Aggregated Age/sex disaggregates |
2015 |
81,188 |
LAB_CAP |
Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests |
2015 |
81 |
PMTCT_ARV |
Life-long ART (including Option B+) |
2015 |
15,597 |
PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
17,146 |
PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
15,597 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
7,799 |
PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
7,798 |
PMTCT_ARV |
Sum of New and Current disaggregates |
2015 |
15,597 |
PMTCT_ARV |
Sum of Regimen Type disaggregates |
2015 |
15,597 |
PMTCT_STAT |
Number of new ANC and L&D clients |
2015 |
168,138 |
PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
152,092 |
TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2015 |
129,374 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2015 |
79,222 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2015 |
42,658 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
121,880 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2015 |
121,880 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2015 |
121,880 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2015 |
22,541 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2015 |
12,543 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
35,084 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2015 |
35,084 |
TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
28,769 |
TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
35,084 |